$10.15
0.01000.10%
At Close: -
$10.30
0.151.48%
After Hours: 5:22 PM EDT
15 minutes delayed
Arcutis Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcutis Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.42 | $-0.57 | 26.3 % |
Mar 2024 | 2024-05-14 | $-0.32 | $-0.73 | 56.2 % |
Dec 2023 | 2024-02-27 | $-0.72 | $-0.77 | 6.49 % |
Sep 2023 | 2023-11-03 | $-0.73 | $-0.86 | 15.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $30.86M | $27.12M | 13.8 % |
Mar 2024 | 2024-05-14 | $49.57M | $14.68M | 237.7 % |
Dec 2023 | 2024-02-27 | $13.53M | $11.34M | 19.3 % |
Sep 2023 | 2023-11-03 | $38.11M | $32.83M | 16.1 % |
Arcutis Biotherapeutics (ARQT) is scheduled to report earnings on November 1, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.42, which beat the estimate of $-0.57.
The Actual Revenue was $30.9M, which beat the estimate of $27.1M.
Browse earnings estimates, EPS, and revenue on all stocks.